Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 11(7): e0158179, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27391902

RESUMO

BACKGROUND: The requirements for magnesium (Mg) supplementation increase under regional citrate anticoagulation (RCA) because citrate acts by chelation of bivalent cations within the blood circuit. The level of magnesium in commercially available fluids for continuous renal replacement therapy (CRRT) may not be sufficient to prevent hypomagnesemia. METHODS: Patients (n = 45) on CRRT (2,000 ml/h, blood flow (Qb) 100 ml/min) with RCA modality (4% trisodium citrate) using calcium free fluid with 0.75 mmol/l of Mg with additional magnesium substitution were observed after switch to the calcium-free fluid with magnesium concentration of 1.50 mmol/l (n = 42) and no extra magnesium replenishment. All patients had renal indications for CRRT, were treated with the same devices, filters and the same postfilter ionized calcium endpoint (<0.4 mmol/l) of prefilter citrate dosage. Under the high level Mg fluid the Qb, dosages of citrate and CRRT were consequently escalated in 9h steps to test various settings. RESULTS: Median balance of Mg was -0.91 (-1.18 to -0.53) mmol/h with Mg 0.75 mmol/l and 0.2 (0.06-0.35) mmol/h when fluid with Mg 1.50 mmol/l was used. It was close to zero (0.02 (-0.12-0.18) mmol/h) with higher blood flow and dosage of citrate, increased again to 0.15 (-0.11-0.25) mmol/h with 3,000 ml/h of high magnesium containing fluid (p<0.001). The arterial levels of Mg were mildly increased after the change for high level magnesium containing fluid (p<0.01). CONCLUSIONS: Compared to ordinary dialysis fluid the mildly hypermagnesemic fluid provided even balances and adequate levels within ordinary configurations of CRRT with RCA and without a need for extra magnesium replenishment. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01361581.


Assuntos
Anticoagulantes/química , Citratos/química , Soluções para Diálise/química , Magnésio/química , Adolescente , Adulto , Idoso , Ácido Cítrico , Estado Terminal , Feminino , Hemofiltração/efeitos adversos , Homeostase , Humanos , Rim/metabolismo , Magnésio/metabolismo , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Diálise Renal , Insuficiência Renal/terapia
2.
Blood Purif ; 41(1-3): 41-7, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26960213

RESUMO

BACKGROUND: The regional citrate anticoagulation (RCA) induces changes in total (Catot) and ionized (Ca2+) calcium. As of now, we do not have much information about parallel changes of total (Mgtot) and ionized (Mg2+) magnesium. METHODS: The authors compared changes of Mg2+ and Mgtot with changes of Ca2+ and Catot in 32 critically ill patients on 4% trisodium citrate (4% TSC) with calcium-free fluids. RESULTS: The median continuous venovenous hemodiafiltration balance of Mgtot was -0.91 (-1.18 to -0.53) mmol/h compared to the median balance of Catot 0.86 (0.08-1.55) mmol/h. Postfilter Mg2+ decreased by 68.3% (70.8-65.6) in parallel (r = 0.41, p = 0.03) to decrease of postfilter Ca2+ (by 70.2% (73.0-66.1)) and was significantly related to the postfilter Ca2+ (r = 0.50, p < 0.001). The decrease of prefilter to postfilter Ca2+ correlated to a dosage of 4% TSC per blood flow (r = 0.37, p = 0.04). CONCLUSIONS: The loss of Mgtot during RCA is not covered by magnesium concentration in ordinary dialysis/substitution fluid and may lead to the depletion of total body magnesium. The postfilter Mg2+ is significantly related to the postfilter Ca2+. Video Journal Club "Cappuccino with Claudio Ronco" at http://www.karger.com/?doi = 440972.


Assuntos
Injúria Renal Aguda/terapia , Anticoagulantes/efeitos adversos , Cálcio/sangue , Citratos/efeitos adversos , Hidratação/efeitos adversos , Hemodiafiltração , Magnésio/sangue , Injúria Renal Aguda/sangue , Injúria Renal Aguda/patologia , Idoso , Anticoagulantes/administração & dosagem , Cátions Bivalentes , Citratos/administração & dosagem , Estado Terminal , Feminino , Hidratação/métodos , Hemofiltração , Humanos , Unidades de Terapia Intensiva , Deficiência de Magnésio/sangue , Deficiência de Magnésio/etiologia , Deficiência de Magnésio/patologia , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Respiração Artificial
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA